DRUG · Mapped RxNorm record
Fulvestrant
Normalized identity: fulvestrantView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Efficacy and Safety of 500mg of Fulvestrant
NCT00585507
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedEfficacy and Safety of 500mg of Fulvestrant
Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Interventions
FulvestrantDRUG · verified · RxNorm: fulvestrant
Sponsors & collaborators
Beth Israel Deaconess Medical Centerlead sponsor
Dana-Farber Cancer Institutecollaborator
Brigham and Women's Hospitalcollaborator
Massachusetts General Hospitalcollaborator
Lowell General Hospitalcollaborator
University of Colorado, Denvercollaborator
University of Maryland Greenebaum Cancer Centercollaborator
South Shore Hospitalcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00585507 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.